Navigation Links
Colorectal cancer survival advantage in MUTYH-associated polyposis
Date:11/2/2010

Survival for colorectal cancer patients with MUTYH-associated polyposis was statistically significantly better than for patients with colorectal cancer from the general population, according to a recent study published online November 2 in The Journal of the National Cancer Institute.

People who inherit a mutation in the MUTYH gene have nearly a 100% risk for developing colon cancer at some point in their lifetimes. But it is unknown whether specific histological and molecular genetic features of cancer associated with this genotype influence tumor behavior and survival.

To determine whether patients with MUTYH-associated polyposis colorectal cancer had different survival rates than control colorectal cancer patients, Maartje Nielsen, M.D., of the Leiden University Medical Center, and colleagues, conducted a multicenter cohort study in Europe that included 147 patients with MUTYH-associated polyposis colorectal cancer and 272 population-based control patients with colorectal cancer. Control and study group patients were matched for country, stage, age and year at diagnosis, and cancer subsite.

The researchers found that survival of patients with MUTYH-associated polyposis colorectal cancer was statistically significantly better than for control patients with colorectal cancer. Their five-year survival rate was 78% compared with 63% for the control group. Survival benefit was higher among patients with stage I and II disease than for those with stage III and IV disease.

The researchers offer a speculation about the better survival rate among the patients with MUTYH-associated polyposis colorectal cancer, compared with the control patients: "A compromised base excision repair system could render MUTYH-associated polyposis colorectal cancer more immunogenic than sporadic colorectal cancers, which are characterized predominantly by chromosomal instability."

In an accompanying editorial, Henry T. Lynch, MD, and Stephen J. Lanspa, MD, of Creighton University, hypothesize that the cancer-causing mutations in MUTYH, as well as in the mismatch repair genes predisposing to Lynch syndrome, are the causal factors for their respective survival advantages. Furthermore, they write, "the ultimate understanding of the pathogenetic pathways elicited by these respective mutations may serve as models for studying both survival and increased virulence of hereditary and sporadic colorectal cancers."


'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. The Right Colorectal Cancer Test for the Right Patient
2. Life Line Screening Offers Special Pricing on Colorectal Home Test Kits in Honor of National Colorectal Cancer Month
3. A new indicator of poor prognosis in node-negative colorectal cancer patients
4. Physicians come together on National Colorectal Cancer Awareness and Screening Day
5. High weight associated with risk of colorectal tumors without microsatellite instability
6. New study implicates health care utilization, over biology, in colorectal cancer disparities
7. Leukemia-related protein 16 and colorectal carcinoma
8. Hispanics live in areas with limited capacity for colorectal cancer screening
9. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
10. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
11. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Natural ... all aspects of people’s health and nutrition, announced its product Leyzene is now ... Natural Subsistence develops nutritional supplements that help people improve all aspects of their ...
(Date:3/23/2017)... ... 23, 2017 , ... The American Board of Quality Assurance and Utilization Review ... dedication to Health Care Quality and Management and Patient Safety. , It is with ... association, but also to the Health Care Quality and Patient Safety movements. Diplomates and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April ... , How will the new EU MDR language change the way manufacturers ...
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... of God. “A Respectful Response To Atheist Manifesto” is the creation of published ... his wife, Nancy, for sixty years. He holds graduate degrees from Kent State ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... health and big data solutions, today reported financial ... month period ended December 31, 2016. ... $2.8 million, increased 241% compared to the full ... growth throughout the entire year  ...
(Date:3/22/2017)... today announced the appointment of Martyn Coombs as Chief ... ImaginAb, said "At ImaginAb we have exciting science and technology. Martyn ... business, particularly in commercializing and making step changes in the value ... our potential." ... Coombs is a recognized industry leader in nuclear medicine and imaging. ...
(Date:3/22/2017)... -- Ablation is the minimally invasive therapeutic tissue excision ... from cancerous or diseased tissue removal, to the ... fibrillation and others. The growing adoption of minimally ... and improvise existing ablation technologies for better patient ... is expected to grow at high single digit ...
Breaking Medicine Technology: